| Line 9: |
Line 9: |
| | '''Pharmacodynamics is the actions of drugs on the body.''' | | '''Pharmacodynamics is the actions of drugs on the body.''' |
| | | | |
| − | For drugs to act upon the body the must be able to exert some chemical influence upon a cell to result in a physiological response. They are capable of doing this by binding to a target molecule (usually proteins). | + | For drugs to act upon the body they must be able to exert some chemical influence upon a cell to result in a physiological response. They are capable of doing this by binding to a target molecule (usually proteins). |
| | | | |
| − | There are four main kinds of targets for the drugs to bind to: | + | There are four main targets which drugs to bind to: |
| | | | |
| | * '''Receptors''' - these are protein molecules that are capable of responding to endogenous chemical signals. They are usually found on the cell membrane, in the cytoplasm or on the nucleus and other organelles. | | * '''Receptors''' - these are protein molecules that are capable of responding to endogenous chemical signals. They are usually found on the cell membrane, in the cytoplasm or on the nucleus and other organelles. |
| Line 41: |
Line 41: |
| | | | |
| | | | |
| − | * The biological response of resulting from an agonist is proportional to the number of receptors occupied. The size of a response can be measured and plotted against the dose/concentration of the agonist. As the size of a response normally increasee in a non-linear manner (until the maximum is reached) the response is normally plotted against the log of the concentration. | + | * The biological response resulting from an agonist binding is proportional to the number of receptors occupied. The size of a response can be measured and plotted against the dose/concentration of the agonist. As the size of a response normally increases in a non-linear manner (until the maximum is reached) the response is normally plotted against the log of the concentration. |
| | | | |
| | | | |
| | '''Please Insert Appropriate Graphs''' | | '''Please Insert Appropriate Graphs''' |
| | + | [[File:Dose-Response Curve.png|thumb|dose-response curve used to calculate EC50]] |
| | | | |
| | From these graphs two figures can be achieved, the '''ED50''' or '''EC50'''. The ED50 is the effective dose at which 50% of a maximal response occurs or 50% of individuals respond. The EC50 is the same but is the effective concentration. Agonists with higher affinities will have a lower concentration and so EC50 than an agonist with a lower affinity. The first drug is therfore said to be more '''potent'''. | | From these graphs two figures can be achieved, the '''ED50''' or '''EC50'''. The ED50 is the effective dose at which 50% of a maximal response occurs or 50% of individuals respond. The EC50 is the same but is the effective concentration. Agonists with higher affinities will have a lower concentration and so EC50 than an agonist with a lower affinity. The first drug is therfore said to be more '''potent'''. |
| Line 60: |
Line 61: |
| | | | |
| | | | |
| − | The difference between the full and partial agonist is it's '''efficacy'''. This is defined as the strength of the tissue response that results from the formation of a agonist-receptor complex. The efficacy of the partial agonist is lower than that of the full agonist. | + | The difference between the full and partial agonist is its '''efficacy'''. This is defined as the strength of the tissue response that results from the formation of a agonist-receptor complex. The efficacy of the partial agonist is lower than that of the full agonist. |
| | | | |
| | It is still unclear why molecules that are chemically very similar have differing efficacies. Only now are the mechanisms behind it being gradually understand. This however doesn't mean that we ignore efficacy. It is of great practical importance as some drugs of equal affinity for a specific receptor may have widely differing efficacy. | | It is still unclear why molecules that are chemically very similar have differing efficacies. Only now are the mechanisms behind it being gradually understand. This however doesn't mean that we ignore efficacy. It is of great practical importance as some drugs of equal affinity for a specific receptor may have widely differing efficacy. |
| − |
| |
| | | | |
| | ===Inverse Agonists=== | | ===Inverse Agonists=== |
| Line 113: |
Line 113: |
| | ===Self-antagonism=== | | ===Self-antagonism=== |
| | | | |
| − | If some drugs are repeadtedly given its effect can decrease. This is called '''tachyphylaxis''' or '''desensitisation'''. If a gradual decrease in response to a drug occurs this is called '''tolerance''' and if the drug looses total therapeutic efficacy it is deemed '''refractory'''. Many types of mechanisms occur to cause this phenomenon, the most important include: | + | If some drugs are repeatedly given its effect can decrease. This is called '''tachyphylaxis''' or '''desensitisation'''. If a gradual decrease in response to a drug occurs this is called '''tolerance''' and if the drug loses total therapeutic efficacy it is deemed '''refractory'''. Many types of mechanisms occur to cause this phenomenon, the most important include: |
| | | | |
| − | * chnage in receptor type | + | * change in receptor type |
| | * loss of receptors | | * loss of receptors |
| | * exhaustion of cell mediators | | * exhaustion of cell mediators |
| Line 121: |
Line 121: |
| | * physiological adaptation | | * physiological adaptation |
| | * active extrusion of the drug from cells | | * active extrusion of the drug from cells |
| − |
| |
| | | | |
| | ===Chemical Antagonism=== | | ===Chemical Antagonism=== |